| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Friday - Sep 11, 2015 |
|||||||||
| Q2 FY16 | $0.44 | $0.40 | $25.54B | $23.22B |
NYSE |
||||
| - | -$0.74 | $0.11 | $710.49M | $645.91M |
NASDAQ |
||||
|
Brady
BRC
|
Q4 FY15 | $0.28 | $0.33 | $288.64M | $350.44M |
NYSE |
|||
|
Adicet Bio
ACET
|
Q4 FY15 | $5.86 | - | $109.82M | - |
NASDAQ |
|||
|
SigmaTron International
SGMA
|
- | $0.16 | - | $64.22M | - |
NASDAQ |
|||
|
RF Industries
RFIL
|
- | $0.02 | $0.07 | $8.90M | $29.12M |
NASDAQ |
|||
|
HomeTrust Bancshares
HTBI
|
- | $0.14 | - | $24.11M | - |
NASDAQ |
|||
|
Optical Cable
OCC
|
Q3 FY15 | -$0.09 | - | $20.78M | - |
NASDAQ |
|||
|
Value Line
VALU
|
- | $0.22 | - | $8.83M | - |
NASDAQ |
|||
|
InnSuites Hospitality Trust
IHT
|
- | -$0.09 | - | $3.51M | - |
AMEX |
|||
|
Relmada Therapeutics
RLMD
|
- | -$6.12 | -$0.36 | - | - |
NASDAQ |
|||
| Show 1 more companies | |||||||||
